Avantax Advisory Services, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Avantax Advisory Services, Inc.

$17.6 Billion
Q2 2025

A detailed history of Avantax Advisory Services, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 4,723 shares of XBI stock, worth $497,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,723

Previous 7,124 33.7%

Holding current value

$497,993

Previous $577,000 32.24%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$69.8 - $85.28 $167,589 - $204,757	-2,401 Reduced 33.7%	4,723 $391,000
Q1 2025 May 06, 2025	SELL	$81.1 - $94.7 $2,433 - $2,841	-30 Reduced 0.42%	7,124 $577,000
Q4 2024 Feb 07, 2025	BUY	$89.81 - $104.0 $34,487 - $39,936	384 Added 5.67%	7,154 $644,000
Q3 2024 Nov 13, 2024	SELL	$90.87 - $102.43 $26,170 - $29,499	-288 Reduced 4.08%	6,770 $668,000
Q2 2024 Aug 09, 2024	SELL	$82.22 - $94.12 $210,565 - $241,041	-2,561 Reduced 26.62%	7,058 $654,000
Q1 2024 May 08, 2024	BUY	$87.05 - $102.89 $123,175 - $145,589	1,415 Added 17.25%	9,619 $912,000
Q4 2023 Feb 07, 2024	SELL	$64.12 - $90.86 $360,675 - $511,087	-5,625 Reduced 40.68%	8,204 $732,000
Q3 2023 Nov 07, 2023	SELL	$71.88 - $85.76 $354,512 - $422,968	-4,932 Reduced 26.29%	13,829 $1.01 Million
Q2 2023 Aug 11, 2023	SELL	$75.38 - $90.23 $117,668 - $140,849	-1,561 Reduced 7.68%	18,761 $1.56 Million
Q1 2023 Apr 28, 2023	SELL	$73.13 - $91.97 $852,037 - $1.07 Million	-11,651 Reduced 36.44%	20,322 $1.55 Million
Q4 2022 Feb 13, 2023	SELL	$76.72 - $85.66 $453,952 - $506,850	-5,917 Reduced 15.62%	31,973 $2.65 Million
Q3 2022 Nov 01, 2022	BUY	$75.06 - $94.9 $644,765 - $815,191	8,590 Added 29.32%	37,890 $3.01 Million
Q2 2022 Aug 02, 2022	BUY	$62.81 - $96.09 $121,537 - $185,934	1,935 Added 7.07%	29,300 $2.18 Million
Q1 2022 Apr 27, 2022	BUY	$81.07 - $115.44 $1 Million - $1.43 Million	12,363 Added 82.41%	27,365 $2.47 Million
Q4 2021 Jan 24, 2022	BUY	$108.77 - $134.15 $139,443 - $171,980	1,282 Added 9.34%	15,002 $1.68 Million
Q3 2021 Oct 21, 2021	BUY	$118.69 - $138.49 $33,589 - $39,192	283 Added 2.11%	13,720 $1.72 Million
Q2 2021 Jul 29, 2021	BUY	$122.48 - $139.69 $11,758 - $13,410	96 Added 0.72%	13,437 $1.82 Million
Q1 2021 May 13, 2021	SELL	$129.36 - $173.99 $2.9 Million - $3.9 Million	-22,415 Reduced 62.69%	13,341 $1.81 Million
Q4 2020 Jan 22, 2021	SELL	$110.36 - $151.14 $1.11 Million - $1.52 Million	-10,087 Reduced 22.0%	35,756 $5.04 Million
Q3 2020 Oct 14, 2020	BUY	$103.87 - $120.36 $874,585 - $1.01 Million	8,420 Added 22.5%	45,843 $5.1 Million
Q2 2020 Aug 06, 2020	BUY	$73.26 - $114.17 $1.68 Million - $2.61 Million	22,869 Added 157.13%	37,423 $4.18 Million
Q1 2020 Apr 30, 2020	BUY	$65.95 - $98.35 $959,836 - $1.43 Million	14,554 New	14,554 $1.13 Million

Others Institutions Holding XBI

# of Institutions

805

Shares Held

112M

Call Options Held

22.4M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History